Back to Search
Start Over
The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia.
- Source :
-
Blood [Blood] 2016 Sep 15; Vol. 128 (11), pp. 1525-8. Date of Electronic Publication: 2016 Jul 11. - Publication Year :
- 2016
- Subjects :
- Antineoplastic Agents pharmacokinetics
Antineoplastic Agents therapeutic use
Arsenic toxicity
Arsenic Trioxide
Arsenicals pharmacokinetics
Arsenicals therapeutic use
Case-Control Studies
Drug-Related Side Effects and Adverse Reactions metabolism
Female
Follow-Up Studies
Humans
Leukemia, Promyelocytic, Acute metabolism
Leukemia, Promyelocytic, Acute mortality
Male
Oxides pharmacokinetics
Oxides therapeutic use
Quality of Life
Survival Analysis
Antineoplastic Agents adverse effects
Arsenic pharmacokinetics
Arsenicals adverse effects
Drug-Related Side Effects and Adverse Reactions epidemiology
Leukemia, Promyelocytic, Acute drug therapy
Leukemia, Promyelocytic, Acute epidemiology
Oxides adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0020
- Volume :
- 128
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Report
- Accession number :
- 27402972
- Full Text :
- https://doi.org/10.1182/blood-2016-02-699439